US Stocks
/
Incyte Corp. Share Price
Incyte Corp. Share Price

Incyte Corp. Share Price

NASDAQ: INCY | Large Cap
$113.36
+$0.52 (0.46%) Last updated on 10 Oct, 2026 | 00:42 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Incyte Corp. Stock Performance

Open
$112.50
Prev. Close
$112.84
Circuit Range
N/A
Day Range
$112.07 - $113.74
Year Range
$82.98 - $132.59
Volume
62,335
Average Traded
$113.09

Incyte Corp. Share Price Today

As of 10 October 2026, Incyte Corp.'s share price is $113.36. The stock opened at $112.50, compared to its previous close of $112.84. During today's trading session, Incyte Corp.'s share price traded between $112.07 and $113.74, with an average price of $112.91. Over the past 52 weeks, the stock has recorded a high of $132.59 and a low of $82.98. In terms of performance, Incyte Corp.'s share price has risen by 18.84% over the last six months and is up 21.27% on a year-on-year basis.

Incyte Corp. Share Price Chart

$112.07$113.74
L
Show Current Price
H

Incyte Corp. Stock Fundamentals & Key Indicators

Market Cap
$22.13B
PE Ratio (TTM)
14.17
Dividend Yield
0.00%
EPS (TTM)
$7.95
Revenue (TTM)
$5.14T
Return On Equity (TTM)
25.41%
Profit Margin
25.03%
Debt to Equity
0.01
Quarterly Earnings Growth YoY
38.06%

Incyte Corp. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$1365.98$1506.84$1272.68$1674.04
Net Profit$424.17$299.28$303.33$585.61
Net Profit Margin31.05%19.86%23.83%34.98%
Income ChangeN/A-29.44%1.35%93.06%

Incyte Corp. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$3394.64$3695.65$4241.22$5141.24
Net Profit$340.66$597.60$32.62$1286.65
Net Profit Margin10.04%16.17%0.77%25.03%
Income ChangeN/A75.42%-94.54%3844.36%

About Incyte Corp.

Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes an array of oncology and dermatology programs.

Incyte Corp. Historical Returns

MonthOpenCloseChange %
Oct 2026
$121.15
$113.25
-6.74%
Sep 2026
$125.08
$121.44
-4.92%
Aug 2026
$120.49
$127.72
+6.91%
Jul 2026
$114.70
$119.47
+5.44%
Jun 2026
$96.33
$113.31
+17.20%
May 2026
$95.22
$96.68
+1.36%
Apr 2026
$94.75
$95.39
+1.34%
Mar 2026
$99.91
$94.13
-7.01%
Feb 2026
$99.55
$101.22
+1.20%
Jan 2026
$98.51
$100.02
+1.25%
Dec 2025
$103.62
$98.79
-5.46%
Nov 2025
$93.95
$104.50
+11.80%

INCY Share Price FAQs

What is Incyte Corp. share price today?

chevron-up
Incyte Corp. share price today is $113.36 as on October 10, 2026 at 12:42 am IST.

What is the 52 week high and 52 week low of Incyte Corp. stock?

chevron-up
The 52 week high of Incyte Corp. stock is $132.59, while the 52 week low is $82.98 as of 10 Oct '26.

What is INCY's market capitalisation today?

chevron-up
INCY market capitalisation is $22.13B as of October 10, 2026, at 12:42 am IST.

What is INCY's net income for the last quarter?

chevron-up
INCY's net income for the last quarter is 585.61B USD.

What is the 5 year returns of INCY?

chevron-up
The 5 year returns of INCY is 69.24% as on 10 Oct '26.

What is the high & low stock price of INCY today?

chevron-up
INCY stock price hit a high of $113.74 and low of $112.07 as of 10 Oct '26.

Can I buy INCY shares in India?

chevron-up
Yes. You can buy INCY in India by opening an international trading account.